RBC Capital lowered the firm’s price target on Walgreens Boots Alliance to $13 from $22 and keeps a Sector Perform rating on the shares. The analyst cites the company’s weaker than expected Q3 results reported last week, along with the management’s guidance cut, while reducing the firm’s FY25 EPS view to $2.10 from $3.20 and noting the continuation of retail and pharmacy headwinds into next year. These include the softer than expected consumer backdrop as well as unfavorable pharmacy mix and reimbursement trends, RBC states, adding that while it is encouraging to see strategic efforts take shape early in the review process, Walgreens management still sees an extended runway to retail turnaround.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- QQQ ETF Update, 7/2/2024
- Walgreens Boots Alliance Stock (NASDAQ:WBA): Here’s Why TD Cowen Slashed its Price Target
- Boots chief quitting as Walgreens’ sale plan stalls, Reuters reports
- Walgreens Boots Alliance price target lowered to $13 from $20 at Truist
- Walgreens Boots Alliance price target lowered to $10 from $17 at Evercore ISI